St Jude ends M&A dry spell with force-sensing heart ablation tech buy
This article was originally published in Clinica
Executive Summary
St Jude Medical has acquired Endosense, a privately-held Swiss company specializing in force-sensing catheter ablation technologies. The acquisition is St Jude’s first significant purchase after a near three-year M&A dry spell, and will strengthen its offerings for cardiac arrhythmia treatment, including the fast-growing atrial fibrillation (AF) segment.